United States · FDA National Drug Code directory
Rivastigmine Tartrate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 60687-777_4352c1c1-8fb2-d457-e063-6294a90ab64b
- Product NDC
- 60687-777
- Form
- CAPSULE
- Composition / generic term
- Rivastigmine Tartrate
- Labeler
- American Health Packaging
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240101
- Source listing expiry
- 20261231
Source-listed ingredients
- RIVASTIGMINE TARTRATE — 1.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 BLISTER PACK in 1 CARTON (60687-777-01) / 1 CAPSULE in 1 BLISTER PACK (60687-777-11) · 60687-777-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →